{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T04:03:00Z","timestamp":1746504180890,"version":"3.40.4"},"reference-count":21,"publisher":"ALUNA","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:p>Aim: To determine how Apelin levels and other biochemical markers affect thyroid function of Iraqi diabetic women.\nMaterials and Methods: 88 subjects participated in this study, 44 diabetic women with hypothyroidism, whose ages between 40 and 60 years, and 44 healthy as a control group, whose ages between 40 and 55 years, during December 2022 to the end of April 2023. Demographic characters such as age, height, and weight of all participants were noted. Serum thyroxin, triiodothyronine and thyroid stimulating hormone were measured by Minivans with Biomerix Kits. Fasting serum glucose, glycated hemoglobin (HbA1c), lipid profile (total cholesterol, triglyceride, high density lipoprotein, and low-density lipoprotein, and very low-density lipoprotein), blood urea, and serum creatinine were among the tests performed on blood samples for the laboratory research. ELISA kit was used to measure amount of apelin.\nResults: A highly significant increase of apelin levels in diabetic women with hypothyroidism when compared with control, a significant positive correlation P &lt;0.05 between Apelin level and each of: weight, body mass index, TSH, glycated hemoglobin (HbA1c), TG and VLDL and shows a highly significant positive correlation P&lt;0.05 between Apelin level vs. TT4, FBS, TC and LDL. A significant negative correlation P&lt;0.05 was found between Apelin levels vs. serum HDL in diabetic women with hypothyroidism.\nConclusions: A significant increase in results of Apelin in women with hypothyroidism and diabetes led to a significant imbalance in lipid metabolism, in the future, this might be an indicator of their risk of heart disease.<\/jats:p>","DOI":"10.36740\/merkur202502110","type":"journal-article","created":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T11:48:13Z","timestamp":1746445693000},"page":"218-221","source":"Crossref","is-referenced-by-count":0,"title":["Effect of apelin level in Iraqi diabetic women with hypothyroidism"],"prefix":"10.36740","volume":"53","author":[{"given":"Maryam Qusay","family":"Isaa","sequence":"first","affiliation":[{"name":"INSTITUTE OF MEDICAL TECHNOLOGY ALMANSURE, MIDDLE TECHNICAL UNIVERSITY, BAGHDAD, IRAQ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noor Thair","family":"Tahir","sequence":"additional","affiliation":[{"name":"NATIONAL DIABETES CENTER, MUSTANSIRIYAH UNIVERSITY, BAGHDAD, IRAQ, IRAQ"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"22436","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Garg MK, Mahalle N, Hari KVS. Laboratory evaluation of thyroid function: Dilemmas and pitfalls. Med J Dr DY. Patil University. 2016;9(4):430-436. doi: 10.4103\/0975-2870.186054","DOI":"10.4103\/0975-2870.186054"},{"key":"ref1","unstructured":"2. Anaya JM, Shoenfeld Y, Rojas-Villarraga A, et al, (eds). Autoimmunity: From Bench to Bedside. Bogota (Colombia): El Rosario University Press; 2013, p. 244."},{"key":"ref2","unstructured":"3. Jedda WAAL, Al-Ali ZAJR, Akram RS. Study the Interferon-\u03b3, C-reactive Protein and Lipid Profile in Iraqi Diabetic Patients with and without Hypertension. NVEO. 2021;8820-32."},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Birtwhistle R, Morissette K, Dickinson JA, Reynolds DL, Avey MT, Reyes Domingo F, Rodin R, Thombs BD. Recommendation on screening adults for asymptomatic thyroid dysfunction in primary care. CMAJ. 2019;191(46):E1274-E1280. doi: 10.1503\/cmaj.190395.","DOI":"10.1503\/cmaj.190395"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Elias NG, Akram RS, Abd Aon YS. Alteration of lipid profile, kidney functions, D-dimer and some anti-inflammatory parameters in samples of Iraqi patients with Covid-19. J Popul Ther Clin Pharmacol. 2023;30(5):515-25.","DOI":"10.47750\/jptcp.2023.30.05.051"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Sharma M, Aronow WS, Patel L, Gandhi K, Desai H. Hyperthyroidism. Med Sci Monit. 2011 Apr;17(4): RA85-91. doi: 10.12659\/msm.881705.","DOI":"10.12659\/msm.881705"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"7. Mullur R, Liu YY, Brent GA Thyroid Hormone Regulation of Metabolism Physiol Rev. 2014 Apr; 94(2):355-82.","DOI":"10.1152\/physrev.00030.2013"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Duntas LH, Brenta GA. Renewed Focus on the Association Between Thyroid Hormones and Lipid Metabolism. Front Endocrinal (Lausanne). 2018 Sep 3;9:511. doi: 10.3389\/fendo.2018.00511.","DOI":"10.3389\/fendo.2018.00511"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Akram RS, Isaa MQ, Mohammed AA. Fetuin-A levels and Insulin Resistance in Obese and Non-Obese Iraqi Children. J Popul Ther Clin Pharmacol. 2023;30(6):414-20.","DOI":"10.47750\/jptcp.2023.30.06.047"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Biondi B, Kahaly GJ, Robertson RP. Thyroid Dysfunction and Diabetes Mellitus: Two Closely Associated Disorders. Endocr Rev. 2019 Jun 1;40(3):789-824. doi: 10.1210\/er.2018-00163.","DOI":"10.1210\/er.2018-00163"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Eom YS, Wilson JR, Bernet VJ. Links between Thyroid Disorders and Glucose Homeostasis. Diabetes Metab J. 2022 Mar;46(2):239-256. doi: 10.4093\/dmj.2022.0013.","DOI":"10.4093\/dmj.2022.0013"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Bukhari SI, Ali G, Memom MY, Sandeelo N, Alvi H, Talib A, Ahmed I, Lal H, Asghar MS, Naseer U. Prevalence and predictors of thyroid dysfunction amongst patients with Type 2 diabetes mellitus in Pakistan. J Family Med Prim Care. 2022 Jun; 11(6): 2739-2743. doi: 10.4103\/jfmpc.jfmpc_2106_21.","DOI":"10.4103\/jfmpc.jfmpc_2106_21"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Oscar H Roa Duenas, Anna C Van der Burgh, Till Ittermann, Symen Ligthart, M Arfan Ikram, Robin Peeters, Layal Chaker, Thyroid Function and the Risk of Prediabetes and Type 2 Diabetes. J Clin Endocrinol Metabol. 2022;107(6):1789-1798. doi:10.1210\/clinem\/dgac006","DOI":"10.1210\/clinem\/dgac006"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Rong-Hsing C, Huey-Yi C, Kee-Ming M, et al. Thyroid diseases increased the risk of type 2 diabetes mellitus: A nation-wide cohort study. Medicine. 2019;98(20):e15631. doi: 10.1097\/MD.0000000000015631.","DOI":"10.1097\/md.0000000000015631"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. Gronich N, Deftereos SN, Lavi I, et al. Hypothyroidism is a risk factor for new-onset diabetes: a cohort study. Diabetes Care 2015;38:1657-64. doi: 10.2337\/dc14-2515.","DOI":"10.2337\/dc14-2515"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16. Palmer ES, Irwin N, O\u2018Harte FP. Potential Therapeutic Role for Apelin and Related Peptides in Diabetes: An Update. Clin Med Insights Endocrinol Diabetes. 2022;15:11795514221074679. doi: 10.1177\/11795514221074679.","DOI":"10.1177\/11795514221074679"},{"key":"ref16","unstructured":"17. Gurel A, Do\u011fantekin A, Ozkan Y, Ayd\u0131n S. Serum apelin levels in patients with thyroid dysfunction. Int J Clin Exp Med. 2015;8(9):16394-8."},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18. Zaki M, Kamal S, Ezzat W, Hassan N, Yousef W, Ryad H, Mohamed R, Youness E, Basha W, Elhosary Y. Serum apelin levels and metabolic risk markers in obese women. J Genet Eng Biotechnol. 2017; 15(2): 423-429. doi: 10.1016\/j.jgeb.2017.05.002.","DOI":"10.1016\/j.jgeb.2017.05.002"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19. Matta RA, Saedii AA. Cross-Talk between Apelin, Insulin Resistance, Thyroid Hormones, and Cardio-metabolic Risk Factors in Polycystic Ovary Syndrome. Egyp J Hosp Med. 2022; 87(1):1635-1643. doi: 10.21608\/ejhm .2022.227708","DOI":"10.21608\/ejhm.2022.227708"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20. Hu G, Wang Z, Zhang R, Sun W, Chen X. The Role of Apelin\/Apelin Receptor in Energy Metabolism and Water Homeostasis: A Comprehensive Narrative Review. Front Physiol. 2021; 12: 632886. doi: 10.3389\/fphys.2021.632886.","DOI":"10.3389\/fphys.2021.632886"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21. Yasar HY, Demirpence M, Colak A, et al. Serum irisin and apelin levels and markers of atherosclerosis in patients with subclinical hypothyroidism. Arch Endocrinol Metab. 2019;63: 16-21. doi: 10.20945\/2359-3997000000106.","DOI":"10.20945\/2359-3997000000106"}],"container-title":["Polski Merkuriusz Lekarski"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T11:48:16Z","timestamp":1746445696000},"score":1,"resource":{"primary":{"URL":"https:\/\/polskimerkuriuszlekarski.pl\/wp-content\/uploads\/library\/PolMerkurLek2025i2net.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":21,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025]]},"published-print":{"date-parts":[[2025,4]]}},"URL":"https:\/\/doi.org\/10.36740\/merkur202502110","archive":["Internet Archive"],"relation":{},"ISSN":["1426-9686"],"issn-type":[{"value":"1426-9686","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}